 |
|
Simple strategy could prevent half of deadly tuberculosis infections
December 19, 2007By using a combination of inexpensive infection control measures, hospitals around the world could prevent half the new cases of extensively drug resistant tuberculosis (XDR TB), according to a new study in The Lancet by researchers at Yale School of Medicine.
Dubbed "Ebola With Wings" for its ability to spread and kill rapidly, XDR TB has been reported in 37 countries and has been identified in all regions of the world, including the United States. The disease has become an epidemic among hospitalized patients in South Africa, according to researchers on the Yale study. Cases of XDR TB have been diagnosed in every province of South Africa, and are particularly concentrated in the area surrounding Tugela Ferry.
To assess the spread of XDR TB, Yale School of Medicine M.D., Ph.D. student Sanjay Basu and the research team developed a computer model of a virtual world that incorporated over two years of data from Tugela Ferry. The model was 95 percent accurate at predicting the trends in XDR and other forms of TB in the region. The Yale study provides the first estimates of the XDR TB burden in South Africa. According to the model over 1,300 cases of XDR TB could arise in the Tugela Ferry region by the end of 2012.
"It is critically important to take steps now to prevent further spread of XDR TB," said Basu. "If we wait to act, this form of TB will spread further in the community and beyond borders. When a drug resistant strain hit New York in the 1990s, it cost over $1 billion to bring under control."
Tuberculosis is caused by bacteria that target the lungs and is spread through the air when an infected person coughs or sneezes. HIV-positive people constitute a vast majority of the XDR TB cases, given their greater risk of infection.
The authors write that the best way to address this type of TB effectively is to change the healthcare environment. Use of masks alone would prevent fewer than 10 percent of cases in the general epidemic, though they would help many healthcare workers, say the researchers. Reducing time spent in the hospital and shifting to outpatient therapy could prevent nearly one-third of cases, they note. About half of XDR TB cases could be prevented by addressing hospital overcrowding, improving ventilation, enhancing access to HIV treatment, and providing faster diagnostic tests, say the study authors.
Basu said that the problem is compounded in South Africa where there are long waiting lists of up to 70 patients hoping to gain admission to hospitals, and crowded wards with as many as 40 people packed into one room. Some of these patients have to sleep on the floor, and many travel for days to reach the hospital.
"We can do a lot to change what is going on," said senior author Gerald Friedland, M.D., a professor of medicine at Yale. "This is a train crash between the two epidemics of HIV and TB, and we have to address both problems together to fix this situation."
Yale University
"It is critically important to take steps now to prevent further spread of XDR TB," said Basu. "If we wait to act, this form of TB will spread further in the community and beyond borders. When a drug resistant strain hit New York in the 1990s, it cost over $1 billion to bring under control."
Tuberculosis is caused by bacteria that target the lungs and is spread through the air when an infected person coughs or sneezes. HIV-positive people constitute a vast majority of the XDR TB cases, given their greater risk of infection.
The authors write that the best way to address this type of TB effectively is to change the healthcare environment. Use of masks alone would prevent fewer than 10 percent of cases in the general epidemic, though they would help many healthcare workers, say the researchers. Reducing time spent in the hospital and shifting to outpatient therapy could prevent nearly one-third of cases, they note. About half of XDR TB cases could be prevented by addressing hospital overcrowding, improving ventilation, enhancing access to HIV treatment, and providing faster diagnostic tests, say the study authors.
Basu said that the problem is compounded in South Africa where there are long waiting lists of up to 70 patients hoping to gain admission to hospitals, and crowded wards with as many as 40 people packed into one room. Some of these patients have to sleep on the floor, and many travel for days to reach the hospital.
"We can do a lot to change what is going on," said senior author Gerald Friedland, M.D., a professor of medicine at Yale. "This is a train crash between the two epidemics of HIV and TB, and we have to address both problems together to fix this situation."
Yale University
Tuberculosis Current Events and Tuberculosis News RSS'Deadly dozen' reports diseases worsened by climate change
Health experts from the Wildlife Conservation Society today released a report that lists 12 pathogens that could spread into new regions as a result of climate change, with potential impacts to both human and wildlife health and global economies.
Disease diagnosis in just 15 minutes
Testing for diseases such as cancer and multiple sclerosis could soon be as simple as using a pregnancy testing kit.
New way to make malaria medicine also first step in finding new antibiotics
University of Illinois microbiology professor William Metcalf and his collaborators have developed a way to mass-produce an antimalarial compound, potentially making the treatment of malaria less expensive.
How to differentiate abdominal tuberculosis from lymphomas?
The incidence of tuberculosis is increasing. Lymphadenopathy is the most common manifestation of abdominal tuberculosis and may, in up to 55% of cases without other evidence of abdominal involvement, be easily confused with lymphomas involving abdominal lymph nodes.
New insights could lead to a better pneumococcal vaccine
Discovery of a new, previously unknown mechanism of immunity suggests that there may be a better way to protect vulnerable children and adults against Streptococcus pneumoniae (pneumococcal) infection, say researchers at Children's Hospital Boston and Harvard School of Public Health (HSPH).
Tuberculosis drug shows promise against latent bacteria
A new study has shown that an investigational drug (R207910, currently in clinical trials against multi-drug resistant tuberculosis strains) is quite effective at killing latent bacteria. This revelation suggests that R207910 may lead to improved and shortened treatments for this globally prevalent disease.
Novel tuberculosis vaccine in Germany in clinical phase
For the first time in more than 80 years a promising live vaccine against tuberculosis has passed into the clinical phase in Germany: Since Monday of this week the new vaccine, which goes by the designation "VPM1002", has begun safety testing on volunteers in a Phase I clinical trial in Neuss, Germany.
New method to overcome multiple drug resistant diseases developed by Stanford researchers
Many drugs once considered Charles Atlases of the pharmaceutical realm have been reduced to the therapeutic equivalent of 97-pound weaklings as the diseases they once dispatched with ease have developed resistance to them.
India continues to progress in AIDS vaccine development efforts
A second Phase I AIDS vaccine clinical trial in India was successfully completed, the Indian Council of Medical Research, the National AIDS Control Organization and the International AIDS Vaccine Initiative announced. The results of the trial of an MVA-based AIDS vaccine candidate (TBC-M4), which was conducted in Chennai, indicated that the vaccine candidate had acceptable levels of safety and was well tolerated.
Extensively drug-resistant tuberculosis found in California
In the first statewide study of extensively drug-resistant tuberculosis (XDR TB) in the United States, California officials have identified 18 cases of the dangerous and difficult-to-treat disease between 1993 and 2006, and 77 cases that were one step away from XDR TB. The study appears in the August 15 issue of Clinical Infectious Diseases, now available online.
More Tuberculosis Current Events and Tuberculosis News Articles
 | The Bioarchaeology of Tuberculosis: A Global View on a Reemerging Disease by CHARLOTTE ROBERTS, JANE BUIKSTRA Though apparently in decline during the first half of the 20th century, tuberculosis has reawakened in both developed and developing countries, particularly among susceptible populations with immunodeficiency disorders.... |
 | Tuberculosis and the Politics of Exclusion: A History of Public Health and Migration to Los Angeles (Critical Issues in Health and Medicine) by Emily K. Abel Though notorious for its polluted air today, the city of Los Angeles once touted itself as a health resort. After the arrival of the transcontinental railroad in 1876, publicists launched a campaign to portray the city as the promised land, circulating countless stories of miraculous cures for the sick and debilitated. As more and more migrants poured in, however, a gap emerged between... |
 | The White Plague: Tuberculosis, Man, and Society by Rene J. Dubos |
 | Living in the Shadow of Death: Tuberculosis and the Social Experience of Illness in American History by Sheila M. Rothman Tuberculosis -- once the cause of as many as one in five deaths in the U.S. -- crossed all boundaries of class and gender, but the methods of treatment for men and women differed radically. While men were encouraged to go out to sea or to the open country, women were expected to stay at home, surrounded by family, to anticipate a lingering death. Several women, however, chose rather to head for... |
 | Captain of Death: The Story of Tuberculosis by Thomas M. Daniel The dramatic story of tuberculosis is told here in a straightforward and accessible style. It presents the stories of persons connected with the disease, either as victims, or as those who made contributions to our knowledge of it; in addition to these personal accounts, the book unfolds the history and explains the pathogenesis of TB. The re-emergence of tuberculosis as a major American public... |
 | Consumed in the City: Observing Tuberculosis at Century's End by Paul Joseph Draus As a public health field worker assigned to control tuberculosis in New York and Chicago in the 1990s, Paul Draus encountered the horrible effects of tuberculosis resurgence in urban areas, and the intersections of disease, blight, and poverty. Consumed in the City grows out of his experiences and offers a persuasive case for thinking about—and treating—tuberculosis as an inseparable... |
 | Tuberculosis Pearls by Neil W. Schluger, Timothy J., M.D. Harkin New York University, New York City. Handbook of 75 clinical case presentations in tuberculosis, with diagnosis, one-page discussion, and pearls. For residents and medical students. Halftone illustrations. DNLM: Tuberculosis, Pulmonary - diagnosis - case... |
 | The Making of a Social Disease: Tuberculosis in Nineteenth-Century France by David S. Barnes In this first English-language study of popular and scientific responses to tuberculosis in nineteenth-century France, David Barnes provides a much-needed historical perspective on a disease that is making an alarming comeback in the United States and Europe. Barnes argues that French perceptions of the disease--ranging from the early romantic image of a consumptive woman to the later view of a... |
 | Clinical Tuberculosis (A Hodder Arnold Publication) by Peter D Davies, Peeter Barnes, Stephen B Gordon Clinical Tuberculosis remains an indispensable resource for respiratory physicians, infectious disease specialists, public health workers and other individuals involved in the management and control of tuberculosis worldwide. This established reference is a comprehensive accoutn of tuberculosis, providing up-to-date and authoritative information on all aspects of the disease. It gives practical... |
 | Contagion and Confinement: Controlling Tuberculosis along the Skid Road by Barron H. Lerner Most historians of tuberculosis have focused on the sanatorium era of the early twentieth century, losing interest in the disease with the discovery of curative antibiotics in the 1940s. In Contagion and Confinement, Barron H. Lerner offers the first in-depth look at the history of tuberculosis control in the antibiotic era, providing a vital account of this neglected chapter in the history of... |
| © 2008 BrightSurf.com |